In these experiments, we utilized fibroblasts derived from sporadic PD patients and LRRK2 mutation carriers and directly compared the phenotypes observed following mitochondrial stress and the beneficial effect of pharmacological LRRK2 kinase inhibition. Here, LRRK2 is linked to Parkinson disease.